“Two-phase”的搜索结果，显示 81-90 项，共有 5935 项

1. 血液科- 临床试验- 妙佑医疗国际

   This phase 1b trial is an open-label study designed to assess the safety ... This study includes 2 parts; step-up dose optimization (Part 1) and dose ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of phase 2 of this trial is to evaluate the effectiveness of sequentially administering temozolomide and selinexor in recurrent glioblastoma as ...

3. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...

4. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of Part 1 of this study is to define the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of CC-220 in ...

6. 外科 - 临床试验- 妙佑医疗国际

   ... phase 2 dose (RP2D) for future study after treatment with SONALA-001 in combination with MRgFUS in subjects with progressive or rGBM. A Vaccine (H2NVAC) ...

7. 血液科- 临床试验- 妙佑医疗国际

   This phase 1b trial is an open-label study designed to assess the safety ... This study includes 2 parts; step-up dose optimization (Part 1) and dose ...

8. 外科 - 临床试验- 妙佑医疗国际

   The purpose of this study is to investigate outcomes for all patients with upper or lower extremity lymphedema with lymph node transfer in a two stage ...

9. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with ...

10. 神经科- 临床试验- 妙佑医疗国际

    ... Phase 2 Dose (RP2D) of NMS-03305293 in combination with temozolomide (TMZ) in patients with diffuse gliomas at first relapse (Phase I), and to determine the ...